| 2023-06-06 |
复牌提示：
2023-06-05 12:42:37 停牌，复牌日期 2023-06-05 16:15:00
|
| 2023-05-11 |
详情>>
股本变动：
变动后总股本221.42万股
|
| 2023-05-11 |
详情>>
业绩披露：
2023年一季报每股收益-2.28美元,归母净利润-505.48万美元,同比去年增长22.20%
|
| 2023-03-30 |
详情>>
业绩披露：
2022年年报每股收益-24.28美元,归母净利润-2159.45万美元,同比去年增长-25.95%
|
| 2022-12-21 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.68美元,归母净利润-1690.19万美元,同比去年增长-41.39%
|
| 2022-10-31 |
股东大会：
将于2022-11-29召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our amended and restated certificate of incorporation to increase the authorized number of shares of our common stock from 26,666,667 to 80,000,000;
2.To approve a series of alternate amendments to our amended and restated certificate of incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio between 1-for-3 and 1-for-12, inclusive, as determined by our Board of Directors in its sole discretion;
3.To authorize an adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1 or Proposal 2;
4.To transact any other business that may be properly brought before the meeting or any continuation, adjournment or postponement thereof.
|
| 2022-08-12 |
详情>>
业绩披露：
2022年中报每股收益-1.3美元,归母净利润-1238.57万美元,同比去年增长-65.96%
|
| 2022-08-11 |
财报披露：
美东时间 2022-08-11 盘后发布财报
|
| 2022-07-07 |
股东大会：
将于2022-08-17召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ three nominees for director named herein to hold office until the 2025 Annual Meeting of Stockholders;
2.To approve a series of alternate amendments to our Amended and Restated Certificate of Incorporation to effect, at the option of the Board of Directors, a reverse stock split of our common stock at a ratio between 1-for-5 and 1-for-15, inclusive, as determined by the Board of Directors in its sole discretion;
3.To approve the authorization to adjourn the annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement accompanying this Notice.
5.To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
6.To conduct any other business properly brought before the meeting or any adjournment thereof.
|
| 2022-05-12 |
详情>>
业绩披露：
2022年一季报每股收益-0.81美元,归母净利润-649.75万美元,同比去年增长-34.02%
|
| 2022-03-29 |
详情>>
业绩披露：
2021年年报每股收益-2.47美元,归母净利润-1714.52万美元,同比去年增长17.85%
|
| 2021-11-10 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.78美元,归母净利润-1195.39万美元,同比去年增长27.90%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-12 |
详情>>
业绩披露：
2021年中报每股收益-1.17美元,归母净利润-746.33万美元,同比去年增长33.18%
|
| 2021-07-07 |
股东大会：
将于2021-08-18召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ two nominees for director named herein to hold office until the 2024 Annual Meeting of Stockholders;
2.To approve the HTG Molecular Diagnostics, Inc. Amended and Restated 2014 Employee Stock Purchase Plan;
3.To approve the authorization to adjourn the annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement accompanying this Notice.
5.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
6.To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
7.To conduct any other business properly brought before the meeting or any adjournment thereof.
|
| 2021-05-13 |
详情>>
业绩披露：
2021年一季报每股收益-0.8美元,归母净利润-484.83万美元,同比去年增长11.17%
|
| 2021-03-25 |
详情>>
业绩披露：
2020年年报每股收益-4.51美元,归母净利润-2087.02万美元,同比去年增长-8.15%
|
| 2020-11-23 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2020-07-07 |
股东大会：
将于2020-08-19召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ three nominees for director named herein to hold office until the 2023 Annual Meeting of Stockholders;
2.To approve the HTG Molecular Diagnostics, Inc. 2020 Equity Incentive Plan;
3.To approve a series of alternate amendments to our Amended and Restated Certificate of Incorporation to effect, at the option of the Board of Directors, a reverse stock split of our common stock at a ratio between 1-for-7 and 1-for-15, inclusive, as determined by the Board of Directors in its sole discretion;
4.To approve a series of alternate amendments to our Amended and Restated Certificate of Incorporation to effect, if and only if Proposal 3 is both approved and implemented, a reduction in the total number of authorized shares of our common stock as illustrated in the table under the caption “Effects of Authorized Shares Reduction” in the section of the accompanying proxy statement entitled “Approval of Reduction in the Number of Authorized Shares of Common Stock”;
5.To approve the authorization to adjourn the annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2 or Proposal 3.
6.To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
7.To conduct any other business properly brought before the meeting or any adjournment thereof.
|
| 2019-07-02 |
股东大会：
将于2019-08-14召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ two nominees for director named herein to hold office until the 2022 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
3.To conduct any other business properly brought before the meeting.
|
| 2018-08-15 |
详情>>
内部人交易：
HANHAM ANN等共交易5笔
|
| 2018-07-03 |
股东大会：
将于2018-08-15召开股东大会
会议内容 ▼▲
- 1. To elect the Board of Directors’ three nominees for director named herein to hold office until the 2021 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018.
3. To conduct any other business properly brought before the meeting.
|
| 2017-07-03 |
股东大会：
将于2017-08-15召开股东大会
会议内容 ▼▲
- 1. To elect the two Class II directors named herein to hold office until the 2020 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017.
3. To conduct any other business properly brought before the meeting.
|
| 2016-07-13 |
股东大会：
将于2016-08-25召开股东大会
会议内容 ▼▲
- 1. To elect the two Class I directors named herein to hold office until the 2019 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
3. To conduct any other business properly brought before the meeting.
|